TickerFactsScreenerDevelopers

ELITE PHARMACEUTICALS INC /NV/ (ELTP) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2011: $2.68M2012: $1.01M2013: $2.32M2014: $3.24M2015: $3.01M2016: $4.48M2017: $5.90M2018: $3.51M2019: $4.70M2020: $10.02M2021: $13.51M2022: $17.47M2023: $17.56M2024: $30.27M2025: $43.96M$43.96M
2011Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$43.96M+45.2%
2024$30.27M+72.4%
2023$17.56M+0.5%
2022$17.47M+29.3%
2021$13.51M+34.9%
2020$10.02M+113.1%
2019$4.70M+33.9%
2018$3.51M-40.5%
2017$5.90M+31.5%
2016$4.48M+48.8%
2015$3.01M-6.9%
2014$3.24M+39.8%
2013$2.32M+128.4%
2012$1.01M-62.1%
2011$2.68M—